MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ARDT — Ardent Health, Inc.
NYSEArdent Health, Inc.
$10.34
+0.09(+0.88%)
- O
- 10.29
- H
- 10.56
- L
- 10.26
- V
- 280.6K
⏱️ End-of-day dataAs of Oct 2, 2026
Ardent Health, Inc. Statistics
Total Valuation
| Market Cap | $1.49B |
| Enterprise Value | $1.65B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 141.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | 36.93 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 15.90 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 28.22 |
| EV / Sales | n/a |
| EV / EBITDA | 127.17 |
| EV / EBIT | 19.01 |
| EV / FCF | -18.69 |
Financial Position
| Current Ratio | 2.12 |
| Quick Ratio | n/a |
| Debt / Equity | 1.30 |
| Debt / EBITDA | 17.32 |
| Debt / FCF | -2.55 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | 33.78% |
| Return on Assets (ROA) | 11.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $2,321 |
| Employee Count | 25,200 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $16.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.61% |
| 50-Day Moving Average | $10.86 |
| 200-Day Moving Average | $9.70 |
| Relative Strength Index (RSI) | 34.86 |
| Average Volume (20 Days) | 435,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $67.19M |
| Operating Income | $80.91M |
| Pretax Income | $74.59M |
| Net Income | $58.49M |
| EBITDA | $12.98M |
| EBIT | $86.80M |
| Earnings Per Share | $0.28 |
Balance Sheet
| Cash & Cash Equivalents | $60.97M |
| Total Debt | $224.81M |
| Net Cash | -$163.84M |
| Net Cash Per Share | $-1.16 |
| Equity (Book Value) | $173.12M |
| Book Value Per Share | $1.23 |
| Working Capital | $106.87M |
Cash Flow
| Operating Cash Flow | $93.49M |
| Capital Expenditures | -$28.09M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -$88.31M |
| FCF Per Share | $-0.63 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.71% |
| FCF Yield | -5.94% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | $4.20 |
| Lynch Upside | -59.38% |
| Graham Number | $2.78 |
| Graham Upside | -73.11% |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |